Skip to main content

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

Include preview-only content
  1. Article

    Open Access

    A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories

    Pancreatic cancer is an aggressive disease that typically presents late with poor outcomes, indicating a pronounced need for early detection. In this study, we applied artificial intelligence methods to clinic...

    Davide Placido, Bo Yuan, Jessica X. Hjaltelin, Chunlei Zheng in Nature Medicine (2023)